MARUCCI, Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.049
EU - Europa 6.166
AS - Asia 2.572
Continente sconosciuto - Info sul continente non disponibili 72
SA - Sud America 67
AF - Africa 12
OC - Oceania 10
Totale 21.948
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.633
CN - Cina 1.856
PL - Polonia 1.484
IT - Italia 1.133
DE - Germania 962
UA - Ucraina 499
SE - Svezia 474
GB - Regno Unito 458
CA - Canada 405
SG - Singapore 366
FR - Francia 341
RU - Federazione Russa 255
FI - Finlandia 246
TR - Turchia 161
IE - Irlanda 116
EU - Europa 71
BE - Belgio 69
BR - Brasile 51
CZ - Repubblica Ceca 39
VN - Vietnam 36
IN - India 30
KR - Corea 27
HK - Hong Kong 23
RO - Romania 22
NL - Olanda 20
IR - Iran 17
CH - Svizzera 9
JP - Giappone 8
MX - Messico 8
AR - Argentina 7
AU - Australia 7
PK - Pakistan 6
AT - Austria 5
ES - Italia 4
GR - Grecia 4
IL - Israele 4
JO - Giordania 4
LB - Libano 4
MA - Marocco 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
DK - Danimarca 3
EC - Ecuador 3
NO - Norvegia 3
SA - Arabia Saudita 3
TW - Taiwan 3
BD - Bangladesh 2
BG - Bulgaria 2
BY - Bielorussia 2
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AS - Samoa Americane 1
AZ - Azerbaigian 1
CM - Camerun 1
CR - Costa Rica 1
HU - Ungheria 1
ID - Indonesia 1
IQ - Iraq 1
KH - Cambogia 1
LK - Sri Lanka 1
LT - Lituania 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
PE - Perù 1
PH - Filippine 1
SM - San Marino 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 21.948
Salva come PNG Salva come JPEG
Città #
Fairfield 1.492
Woodbridge 1.482
Jacksonville 1.207
Warsaw 1.148
Chandler 948
Houston 793
Ashburn 785
Ann Arbor 709
Wilmington 684
Seattle 627
Cambridge 543
Boardman 509
Nanjing 407
Kraków 331
Toronto 282
Singapore 247
Camerino 200
San Mateo 185
Düsseldorf 171
Beijing 164
Lawrence 163
Princeton 163
Dearborn 158
Columbus 139
Istanbul 138
Ogden 136
Nanchang 125
Lachine 117
Dublin 114
London 109
Shanghai 103
Helsinki 102
Moscow 87
Kunming 86
Guangzhou 79
San Diego 75
Milan 72
Brussels 66
Shenyang 64
Hebei 61
Jiaxing 61
Tianjin 59
New York 56
Los Angeles 51
Chicago 42
Hangzhou 42
Wuhan 38
Centro 37
Munich 37
Venezia 36
Ningbo 35
Philadelphia 35
Changsha 33
Dong Ket 31
Hefei 31
Redwood City 30
Brno 28
Jinan 27
Venice 26
Orange 25
Norwalk 24
Perugia 24
Falls Church 23
Bremen 22
Buffalo 21
Nürnberg 21
Yiwu 21
Verona 19
Zhengzhou 18
Rome 17
Old Bridge 16
Auburn Hills 15
Nantong 15
Scafati 15
Kocaeli 14
Lanzhou 14
Shenzhen 14
Council Bluffs 13
San Francisco 13
Frankfurt am Main 12
Jinhua 12
New Bedfont 12
Tappahannock 12
Tulsa 12
West Jordan 12
Changchun 11
Leawood 11
Horia 10
Osimo 10
Pescara 10
Ardabil 9
Bologna 9
Caserta 9
Hounslow 9
Mountain View 9
Scuola 9
Simi Valley 9
Taizhou 9
Wuxi 9
Buti 8
Totale 16.383
Salva come PNG Salva come JPEG
Nome #
The Length and Flexibility of the 2-Substituent of 9-Ethyladenine Derivatives Modulate Affinity and Selectivity for the Human A2A Adenosine Receptor 333
Overview on Radiolabel-Free in Vitro Assays for GPCRs 319
A2AR agonists/A3R antagonists: design, synthesis, and biological evaluation of new ligands with dual activity 287
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype 283
2′,3′-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 269
Pharmacological characterization of the GPR17 receptor dual profile 269
2’,3’-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 260
The G Protein-Coupled Receptor GPR17: Overview and Update 253
“Synthesis and α-Adrenoreceptor Blocking Properties of Phenoxybenzamine-Related (2-Chloroethyl)-(2,3-dihydrobenzo-[1,4] dioxin-2-ylmethyl)-(2-phenoxyethyl) Amines”. 241
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: Structure-affinity/activity relationship at α1-adrenoceptor subtypes and at 5-HT1A receptors. 241
1,2,4-Benzothiadiazine derivatives as alpha1 and 5-HT1A receptor ligands 234
Synthesis and pharmacological profile of a series of 1-substituted-2-carbonyl derivatives of diphenidol: novel M4 muscarinic receptor antagonists 221
Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia 214
Adenine based acyclic-nucleotides as novel P2X3 receptor ligands 212
“1,3 Oxathiolane Muscarinic Ligands Modified at the Cationic Head”. 208
Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists 206
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor 198
1,3-Dioxolane-based ligands as a novel class of alpha(1)-adrenoceptor antagonists 192
Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists 191
“New Pyridazinones: Synthesis and Correlation Between Structure and α-Blocking Activity”. 190
GPR17 receptor modulators and their therapeutic implications: review of recent patents 189
4-(4-Fluorobenzoyl)-1-[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]piperidine and its derivatives: synthesis and affinity at 5-HT2A, 5-HT2B and 5-HT2c serotonin receptors 187
Synthesis and antimuscarinic activity of derivatives of 2-substituted-1,3-dioxolanes 185
1,3-Dioxolane-based ligands as rigid analogues of Naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors. 183
Neuropeptide S Receptor: recent updates on non-peptide antagonist discovery 180
Purinergic P2X receptors: Structural models and analysis of ligand-target interaction 176
Antiproliferative Evaluation of Isofuranodiene on Breast and Prostate Cancer Cell Lines 173
Antioxidant-conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain 172
Synthesis and alpha1-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin 171
Synthesis and structure-activity relationships of novel arylpiperazines as potent antagonists of α1-adrenoceptor 171
Levels of polychlorinated biphenyls in fish and shellfish from the Adriatic Sea 168
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine 167
Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications. 166
Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity 164
Ex-vivo absorption study of lysine R-lipoate salt, a new pharmaceutical form of R-ALA 163
New sensible method to quantize the intestinal absorption of receptor ligands 163
“Third Joint Italian-German Purine Club Meeting - Purinergic Receptors: New Frontiers for Novel Therapies” 161
Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A2A adenosine receptor binding site 161
Benzimidazole, benzoxazole and benzothiazole derivatives as 5HT(2B) receptor ligands. Synthesis and preliminary pharmacological evaluation 159
Structure-activity relationships of methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists. 3. Effect of inserting the tetraamine backbone into a macrocyclic structure 158
Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A1 and A2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells 158
Synthesis and pharmacological characterization of enantiomerically pure muscarinic agonists: difluoromuscarines 157
Comparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1 157
Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives 157
Simplified analogues of Ritanserin and their affinity at 5-HT2A, 5-HT2B and 5-HT2C serotonin receptors 156
New substituted 9-propyladenine derivatives as A2Aadenosine receptor antagonists 156
Evidence for the existence of a specific G protein-coupled receptor activated by guanosine 154
Determination of Muscarinic Agonist Potencies at M1 and M2 Muscarinic Receptors in a Modified Pithed rat Preparation 153
“Dialkylaminoalkyl Esters of 2,2 Diphenyl-2-Alkylthioacetic Acids: A New Class of Potent and Functionally Selective Muscarinic Antagonists”. 153
Non-Nucleoside Agonists of the Adenosine Receptors: An Overview 153
Antiviral properties of deazaadenine nucleoside derivatives 153
Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice 153
Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17 152
Synthesis and α1-antagonist activity of derivatives of 4-chloro-5-{4-[2-(2-methoxyphenoxy)-ethyl]-1-piperazinyl}-3(2H)-pyridazinone 152
Molecular modeling studies on the human neuropeptide S receptor and its antagonists. 151
Molecular modeling study on potent and selective adenosine A3 receptor agonists. 151
Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. 150
Identification of alpha(1)-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens 149
null 149
“N,N-diethylaminoethanol and N-methyl-4-piperidinol Esters of 2,2-diphenyl-2-Ethylthioacetic Acid as Potent and Selective Muscarinic Antagonist”. 148
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds 147
“Pharmacological Characterization of Muscarinic Receptor Subtypes in Rabbit Isolated Tissue Preparations” 147
The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors 147
Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure 146
Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: The discovery of new functionally selective muscarinic agonists 146
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications 146
Synthesis and antagonistic activity at muscarinic receptor subtypes of some derivatives of diphenidol 145
Synthesis and pharmacological characterization of new chiral derivatives of muscarine and allo-muscarine 143
Muscarinic subtypes profile modulation within a series of new antagonists, bridged bicyclic derivatives of 2,2-diphenyl-[1,3]-dioxolan-4-ylmethyl-dimethylamine 142
Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: Insight into the receptor activation switch 142
“Novel and Highly Selective Postsynaptic α-Adrenoreceptor Antagonists: Synthesis and Structure-Activity Relationships of Alkane-Bridged [4-(phenoxyethyl)-1-piperazinyl]-3 (2H)-pyridazinones”. 142
“Synthesis and Pharmacological Activity of Some New Pyridazinones”. 141
Deoxamuscaroneoxime Devatives as useful Muscarinic Aginist to Explore the Muscarinic Subsite: Demox, Amodulator of Orthosteric and Allosteric Site at Cardiac Muscarinic M2 Receptors. 140
Highly chiral muscarinic ligands: The discovery of (2S,2 ' R,3 ' S,5 ' R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M-2 partial agonist 140
Adenosine receptor modeling: what does the A2A crystal structure tell us? 140
Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors 140
“Synthesis and α1-Antagonist Activity of New Prazosin-and Benextramine-Related Tetraamine Disulfides”. 139
Structure-Activity Relationships of Methoctramine-Related Polyamines as Muscular Nicotinic Receptor Noncompetitive Antagonists. 2. Role of Polymethylene Chain Lengths Separating Amine Functions and of Substituents on the Terminal Nitrogen Atoms. 139
Chiral analogues of (+)-cyclazosin as potent α1B-adrenoceptor selective antagonist 139
Adenosine A(2A) receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's disease 138
(2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenyl-propyl)-amine: a Potent and Selective 5-HT1A Receptor Agonist 138
“Synthesis and Pharmacological Evaluation of Enantiomerically Pure 4-Deoxy-4-Fluoro-Muscarines”. 136
14th Camerino-Noordwijkerhout Symposium - Ongoing Progress in Receptor Chemistry 135
Polyamines may modulate both G protein-coupled receptors and G proteins. 135
Molecular modulation of muscarinic antagonists. Synthesis and affinity profile of 2,2-diphenyl-2-ethylthio-acetic acid esters designed to probe the binding site cavity. 132
A(2A) Adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists 131
Molecular modulation of muscarinic antagonists. Synthesis and pharmacological profile of 2,2-diphenyl-2-ethylthioacetic and 3,3-diphenyl-3-ethylthiopropionic acid derivatives characterized by a dipeptide spacer. 131
SAR Studies on the Potent and Selective Muscarinic Antagonist 2-Ethylthio-2,2-diphenylacetic Acid N,N-Diethylaminoethyl Ester 131
(+)-Cyclazosin derivatives as α1-adrenoceptor antagonists 130
Synthesis and antagonistic activity at muscarinic receptor subtypes of some 2-carbonyl derivatives of diphenidol 129
Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes 128
Synthesis, Affinity Profile and Functional Activity of Potent Chiral Muscarinic Antagonists with a Pyrrolidinylfuran Structure 128
Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists 125
Structure-Activity Relatioships Among Novel Phenoxybenzamine-Related Beta-Chloroethylamines. 124
Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics 123
Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl) pyrrolidine sulfoxide derivatives 123
(+)-Cyclazosin, a selective alpha1B-adrenoceptor antagonist: Functional evaluation in rat and rabbit tissues 122
Human adenosine A3 receptor as selective target of new 2-aralkynyl-N6-methyl-MECA derivatives 122
5HT2B receptor antagonists: a probe for spotting the pharmacophore 118
Searching for cyclazosin analogues as alfa1B-adrenoceptor antagonists 115
Totale 16.705
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.411
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.225 0 0 0 0 0 406 374 414 297 270 159 305
2020/20213.863 208 358 256 299 238 362 629 95 318 188 556 356
2021/20221.977 189 478 39 103 99 65 100 154 145 228 147 230
2022/20232.322 257 120 84 384 260 312 13 146 385 121 170 70
2023/20241.769 252 102 112 59 71 115 86 103 198 70 63 538
2024/20251.590 203 146 485 264 159 333 0 0 0 0 0 0
Totale 22.412